Quantcast

Latest Anadis Stories

2008-10-22 09:00:10

Anadis, a biopharmaceutical company, has announced that it has been informed by the Australian National Center in HIV Epidemiology and Clinical Research and the University of New South Wales, both in Sydney, that their institutional review board has approved a major, Phase IV multisite randomized double-blind placebo controlled study of the company's new product, BioGard. In the study, Anadis's BioGard will be used alone and in combination with the new Merck anti-AIDS drug Isentress...

2008-10-21 21:00:09

Anadis Ltd. (ANX.AX ; ANDIY.PK; CUSIP: 032517104) announced today that it has been informed by the Australian National Center in HIV Epidemiology and Clinical Research (NCHECR) and the University of New South Wales (UNSW), both in Sydney, that their Institutional Review Board has approved a major, phase IV multi-site randomized double-blind placebo controlled study of Anadis' newest product, BioGard(TM). In the study, Anadis' BioGard will be used alone and in combination with the new Merck...

2008-09-04 06:00:24

Anadis (ASX: ANX; OTC: ANDIY) announced today its commercialization of a new product, BioGard(TM), intended to maintain gastrointestinal and immune system health. The specific formulation may be of particular clinical benefit in persons undergoing antiretroviral therapy for HIV/AIDS. The product is intended to enhance current treatment regimens and improve the efficacy of immune system repair during highly active antiretroviral treatment (HAART) treatment. The gastrointestinal immune system...

2008-09-03 00:00:24

Anadis Ltd. (ASX:ANX; OTC:ANDIY) an Australian biopharmaceutical company specializing in oral immunotherapy using naturally derived antibodies and other proteins is announcing the clinical protocol for its Cancer-related Mucositis Program was cleared by the Tel Aviv Souraski Medical Center's Institutional Review Board (IRB) and by the Israeli Ministry of Health (MOH). This enables the initiation of the clinical trial addressing this significant target at the medical center within a month....

2008-07-02 18:00:33

Anadis Ltd. (ASX:ANX; OTC:ANDIY) an Australian biopharmaceutical company has been awarded a product development grant for its Cancer-related Alimentary Mucositis project. The award was one of only three made by the VISTECH bi-national fund, following a competitive process, which included a thorough scientific assessment. The fund was established by the Government of Victoria (Australia) and the Government of Israel through the Office of the Chief Scientist in its Ministry of Industry Trade...


Word of the Day
baudekin
  • A rich embroidered or brocaded silk fabric woven originally with a warp of gold thread.
'Baudekin' seems to be an alternative form of 'baldachin,' from the Italian 'Baldacco,' Baghdad, the city where the material was made.
Related